Discuss basic concepts related to the definition, classification, structure, pathophysiology, natural history and prognosis of patients with hypertrophic cardiomyopathy (HCM). |
|
|
|
|
|
|
Explain the three pillars of management of patients with HCM: 1) treatment or prevention of symptoms, 2) family screening, and 3) assessment and prevention of sudden cardiac death. |
|
|
|
|
|
|
Describe the risk factors and shared decision making utilized to stratify patients with HCM for sudden cardiac death. |
|
|
|
|
|
|
Discuss the use, indications and outcomes of the new myosin inhibitors used for HCM. |
|
|
|
|
|
|
Identify new frontiers for the care of patients with HCM. |
|
|
|
|
|
|